110 related articles for article (PubMed ID: 22407943)
1. ERBB2 overexpression triggers transient high mechanoactivity of breast tumor cells.
Martin M; Müller K; Cadenas C; Hermes M; Zink M; Hengstler JG; Käs JA
Cytoskeleton (Hoboken); 2012 May; 69(5):267-77. PubMed ID: 22407943
[TBL] [Abstract][Full Text] [Related]
2. Expression of matrix metalloproteinases (MMPs) in primary human breast cancer: MMP-9 as a potential biomarker for cancer invasion and metastasis.
Merdad A; Karim S; Schulten HJ; Dallol A; Buhmeida A; Al-Thubaity F; Gari MA; Chaudhary AG; Abuzenadah AM; Al-Qahtani MH
Anticancer Res; 2014 Mar; 34(3):1355-66. PubMed ID: 24596383
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of urokinase-type plasminogen activator mRNA determines adverse prognosis in ErbB2-positive primary breast cancer.
Urban P; Vuaroqueaux V; Labuhn M; Delorenzi M; Wirapati P; Wight E; Senn HJ; Benz C; Eppenberger U; Eppenberger-Castori S
J Clin Oncol; 2006 Sep; 24(26):4245-53. PubMed ID: 16963728
[TBL] [Abstract][Full Text] [Related]
4. Metastasis suppressor 1 (MTSS1) demonstrates prognostic value and anti-metastatic properties in breast cancer.
Parr C; Jiang WG
Eur J Cancer; 2009 Jun; 45(9):1673-83. PubMed ID: 19328678
[TBL] [Abstract][Full Text] [Related]
5. Mammary tumor formation and metastasis evoked by a HER2 splice variant.
Alajati A; Sausgruber N; Aceto N; Duss S; Sarret S; Voshol H; Bonenfant D; Bentires-Alj M
Cancer Res; 2013 Sep; 73(17):5320-7. PubMed ID: 23867476
[TBL] [Abstract][Full Text] [Related]
6. JAM-A expression positively correlates with poor prognosis in breast cancer patients.
McSherry EA; McGee SF; Jirstrom K; Doyle EM; Brennan DJ; Landberg G; Dervan PA; Hopkins AM; Gallagher WM
Int J Cancer; 2009 Sep; 125(6):1343-51. PubMed ID: 19533747
[TBL] [Abstract][Full Text] [Related]
7. Global characterization of signalling networks associated with tamoxifen resistance in breast cancer.
Browne BC; Hochgräfe F; Wu J; Millar EK; Barraclough J; Stone A; McCloy RA; Lee CS; Roberts C; Ali NA; Boulghourjian A; Schmich F; Linding R; Farrow L; Gee JM; Nicholson RI; O'Toole SA; Sutherland RL; Musgrove EA; Butt AJ; Daly RJ
FEBS J; 2013 Nov; 280(21):5237-57. PubMed ID: 23876235
[TBL] [Abstract][Full Text] [Related]
8. ERBB2-mediated transcriptional up-regulation of the alpha5beta1 integrin fibronectin receptor promotes tumor cell survival under adverse conditions.
Spangenberg C; Lausch EU; Trost TM; Prawitt D; May A; Keppler R; Fees SA; Reutzel D; Bell C; Schmitt S; Schiffer IB; Weber A; Brenner W; Hermes M; Sahin U; Türeci O; Koelbl H; Hengstler JG; Zabel BU
Cancer Res; 2006 Apr; 66(7):3715-25. PubMed ID: 16585198
[TBL] [Abstract][Full Text] [Related]
9. Expression of breast cancer metastasis suppressor-1, BRMS-1, in human breast cancer and the biological impact of BRMS-1 on the migration of breast cancer cells.
Zhang Y; Ye L; Tan Y; Sun P; Ji K; Jiang WG
Anticancer Res; 2014 Mar; 34(3):1417-26. PubMed ID: 24596389
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional profiling of ErbB signalling in mammary luminal epithelial cells--interplay of ErbB and IGF1 signalling through IGFBP3 regulation.
Worthington J; Bertani M; Chan HL; Gerrits B; Timms JF
BMC Cancer; 2010 Sep; 10():490. PubMed ID: 20840765
[TBL] [Abstract][Full Text] [Related]
11. Copine-III interacts with ErbB2 and promotes tumor cell migration.
Heinrich C; Keller C; Boulay A; Vecchi M; Bianchi M; Sack R; Lienhard S; Duss S; Hofsteenge J; Hynes NE
Oncogene; 2010 Mar; 29(11):1598-610. PubMed ID: 20010870
[TBL] [Abstract][Full Text] [Related]
12. Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies.
Jardé T; Caldefie-Chézet F; Goncalves-Mendes N; Mishellany F; Buechler C; Penault-Llorca F; Vasson MP
Endocr Relat Cancer; 2009 Dec; 16(4):1197-210. PubMed ID: 19661131
[TBL] [Abstract][Full Text] [Related]
13. ErbB2-enhanced invasiveness of H-Ras MCF10A breast cells requires MMP-13 and uPA upregulation via p38 MAPK signaling.
Yong HY; Kim IY; Kim JS; Moon A
Int J Oncol; 2010 Feb; 36(2):501-7. PubMed ID: 20043086
[TBL] [Abstract][Full Text] [Related]
14. ERBB2 induces an antiapoptotic expression pattern of Bcl-2 family members in node-negative breast cancer.
Petry IB; Fieber E; Schmidt M; Gehrmann M; Gebhard S; Hermes M; Schormann W; Selinski S; Freis E; Schwender H; Brulport M; Ickstadt K; Rahnenführer J; Maccoux L; West J; Kölbl H; Schuler M; Hengstler JG
Clin Cancer Res; 2010 Jan; 16(2):451-60. PubMed ID: 20068093
[TBL] [Abstract][Full Text] [Related]
15. [Study of the correlation between HER-2 gene and lymphangiogenesis and their prognostic significance in human breast cancer].
Zhang GH; Yang WT; Zhou XY; Zeng Y; Lu HF; Shi DR
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):155-60. PubMed ID: 17425844
[TBL] [Abstract][Full Text] [Related]
16. HDAC inhibitor SNDX-275 induces apoptosis in erbB2-overexpressing breast cancer cells via down-regulation of erbB3 expression.
Huang X; Gao L; Wang S; Lee CK; Ordentlich P; Liu B
Cancer Res; 2009 Nov; 69(21):8403-11. PubMed ID: 19826038
[TBL] [Abstract][Full Text] [Related]
17. Role of the focal adhesion protein kindlin-1 in breast cancer growth and lung metastasis.
Sin S; Bonin F; Petit V; Meseure D; Lallemand F; Bièche I; Bellahcène A; Castronovo V; de Wever O; Gespach C; Lidereau R; Driouch K
J Natl Cancer Inst; 2011 Sep; 103(17):1323-37. PubMed ID: 21832234
[TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
[TBL] [Abstract][Full Text] [Related]
19. P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation.
Paredes J; Albergaria A; Oliveira JT; Jerónimo C; Milanezi F; Schmitt FC
Clin Cancer Res; 2005 Aug; 11(16):5869-77. PubMed ID: 16115928
[TBL] [Abstract][Full Text] [Related]
20. c-Kit is suppressed in human colon cancer tissue and contributes to L1-mediated metastasis.
Gavert N; Shvab A; Sheffer M; Ben-Shmuel A; Haase G; Bakos E; Domany E; Ben-Ze'ev A
Cancer Res; 2013 Sep; 73(18):5754-63. PubMed ID: 24008320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]